ChemRxiv · 2021 · 46 citations · 59 references
PharmacyBiochemistryMedicinal ChemistryDrug DiscoveryProtein BiochemistryProteomicsProteomic ProfilingSelectivity ProfilingAmino AcidsCovalent InhibitorsCysteine Reactivity ProfilingCysteine-targeted InhibitorsElectrophile-based ProbesProbe Selectivity AssessmentProteome-wide ProfilingProteome-wide Selectivity Profiling
Targeted covalent inhibitors are powerful entities in drug discovery, but their application has so far mainly been limited to addressing cysteine residues. The development of cysteine-directed covalent inhibitors has largely profited from determining their proteome-wide selectivity using competitive residue-specific proteomics. Several probes have recently been described to monitor other amino acids using this technology and many more electrophiles exist to modify proteins. Nevertheless, a direct, proteome-wide comparison of the selectivity of diverse probes is still entirely missing. Here, we developed a completely unbiased workflow to analyse electrophile selectivity proteome-wide and applied it to directly compare 54 alkyne probes containing diverse reactive groups. In this way, we verified and newly identified probes to monitor a total of nine different amino acids as well as the N-terminus proteome-wide. This selection includes the first probes to globally monitor tryptophans, histidines and arginines as well as novel tailored probes for methionines, aspartates and glutamates.
59